Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Highly ConservedNeisseria meningitidisInner‐Core Lipopolysaccharide Epitope Confers Protection against Experimental Meningococcal Bacteremia

15 Apr 2003

Abstract excerpt

Inner-core lipopolysaccharide (LPS) from Neisseria meningitidis is under investigation as a vaccine for prevention of meningococcal disease caused by N. meningitidis serogroup B (NmB). We investigated the functional activity of murine monoclonal antibody (MAb) B5 that recognizes a highly conserved (galE) LPS epitope. Three patterns of MAb reactivity were observed in N. meningitidis by Western blot, depending on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Infections and Vaccines
Share to Immune Response and Inflammation
Share to Pneumonia and Respiratory Infections

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12696001
DOI: 10.1086/368360

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Highly ConservedNeisseria meningitidisInner‐Core Lipopolysaccharide Epitope Confers Protection against Experimental Meningococcal BacteremiaPMID 12696001Read ↗

Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B.Semantic proximity Read ↗

Structural analysis of the lipopolysaccharide from Neisseria meningitidis strain BZ157 galE: localisation of two phosphoethanolamine residues in the inner core oligosaccharide.Semantic proximity Read ↗

Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity.Semantic proximity Read ↗

How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective<i>Neisseria meningitidis</i>VaccinesSemantic proximity Read ↗

Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome SequencingSemantic proximity Read ↗

Lipopolysaccharide engineering in Neisseria meningitidis: structural analysis of different pentaacyl lipid A mutants and comparison of their modified agonist properties.Semantic proximity Read ↗

Rationally designed minimized TbpB confers broad protection against meningococcal infectionSemantic proximity Read ↗

Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.Semantic proximity Read ↗

Lipooligosaccharide structure contributes to multiple steps in the virulence of Neisseria meningitidis.Semantic proximity Read ↗

Strategies for Development of Universal Vaccines Against Meningococcal Serogroup B DiseaseSemantic proximity Read ↗

Carbohydrate based meningococcal vaccines: past and present overviewSemantic proximity Read ↗

Protective Activity of Monoclonal Antibodies to Genome-Derived Neisserial Antigen 1870, a Neisseria meningitidis Candidate VaccineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.